134 related articles for article (PubMed ID: 30504207)
1. Treating childhood acute lymphoblastic leukemia in a country with no pediatric hematologist/oncologist: a Belize/Mérida joint venture.
Grant E; González-Montalvo P; Pantoja-Guillén F; Escamilla G
Blood Adv; 2018 Nov; 2(Suppl 1):67-68. PubMed ID: 30504207
[No Abstract] [Full Text] [Related]
2. Treatment of childhood acute lymphoblastic leukemia at a regional non-academic center in Belarus.
Chunikhovskiy SP; Zelterman D; van Hoff J
Med Pediatr Oncol; 2002 Sep; 39(3):202-6. PubMed ID: 12210452
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of acute myelocytic leukemia in children.
Lie SO; Jonmundsson GK; Mellander L; Siimes MA; Yssing M; Gustafsson G
Ann N Y Acad Sci; 1997 Sep; 824():84-90. PubMed ID: 9382458
[No Abstract] [Full Text] [Related]
4. Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G; Sidi V; Koliouskas D
Pediatr Blood Cancer; 2007 Oct; 49(5):764. PubMed ID: 17216599
[No Abstract] [Full Text] [Related]
5. Curability of cancer in childhood and adolescence: acute lymphoblastic leukemia.
Mann G; Gadner H
Wien Klin Wochenschr; 2002 Feb; 114(4):141-2. PubMed ID: 12060979
[No Abstract] [Full Text] [Related]
6. Implementation of a graduated-intensity approach for acute lymphoblastic leukemia in a Rwandan district hospital.
Manirakiza A; Dugan G; Hanna C; Nguyen C; Fadelu T; Iradukunda E; Fehr AE; Ruhangaza D; Albert E; Mpunga T; Shyirambere C; Lehmann L
Blood Adv; 2018 Nov; 2(Suppl 1):19-20. PubMed ID: 30504191
[No Abstract] [Full Text] [Related]
7. Shortage of chemotherapeutic agents in Iraq and outcome of childhood acute lymphocytic leukemia, 1990-2002.
Frangoul H; Al-Jadiry MF; Shyr Y; Ye F; Shakhtour B; Al-Hadad SA
N Engl J Med; 2008 Jul; 359(4):435-7. PubMed ID: 18650525
[No Abstract] [Full Text] [Related]
8. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
9. [High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol].
Castell V; Verdaguer A; Ferris J; Piqueras AI; Fernández JM
An Esp Pediatr; 1988 Oct; 29 Suppl 34():89-91. PubMed ID: 3214045
[No Abstract] [Full Text] [Related]
10. [High-risk acute lymphoblastic leukemia].
Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S
An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041
[No Abstract] [Full Text] [Related]
11. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.
Chen SH
Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726
[TBL] [Abstract][Full Text] [Related]
12. Retrospective review of pediatric patients with acute lymphoblastic leukemia: a single center experience.
Khalid S; Moiz B; Adil SN; Khurshid M
Indian J Pathol Microbiol; 2010; 53(4):704-10. PubMed ID: 21045397
[TBL] [Abstract][Full Text] [Related]
13. Genome study suggests new treatments for high-risk form of childhood leukemia.
McBride D
ONS Connect; 2012 Nov; 27(11):21. PubMed ID: 23316525
[No Abstract] [Full Text] [Related]
14. Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents.
Sonnemann J; Gruhn B; Wittig S; Becker S; Beck JF
Br J Haematol; 2012 Sep; 158(5):664-6. PubMed ID: 22686282
[No Abstract] [Full Text] [Related]
15. The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
Antillón FG; Blanco JG; Valverde PD; Castellanos M; Garrido CP; Girón V; Letona TR; Osorio EJ; Borrayo DA; Mack RA; Melgar MA; Lorenzana R; Ribeiro RC; Metzger M; Conter V; Rossi E; Valsecchi MG
Cancer; 2017 Feb; 123(3):436-448. PubMed ID: 27683100
[TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M;
Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816
[TBL] [Abstract][Full Text] [Related]
17. Childhood acute lymphoblastic leukemia managed in tertiary care center in a developing country.
Dabbous IA; Dbouk H; Sibai AM; Bahlawan L
Med Pediatr Oncol; 2003 Jul; 41(1):83-4. PubMed ID: 12764756
[No Abstract] [Full Text] [Related]
18. [Results of the treatment for infant acute lymphoblastic leukemia treated in the program Dana-Faber Cancer Institute. Report of Polish Pediatric Study Group for Leukemia and Lymphoma].
Sońta-Jakimczyk D; Olejnik I; Armata J; Bogusławska-Jaworska J; Kołecki P; Kowalczyk J; Rokicka-Milewska R; Chybicka A; Derwich K; Drabko K; Hicke-Roberts A; Kubiczek K; Steczowicz M
Wiad Lek; 1998; 51 Suppl 4():52-8. PubMed ID: 10731944
[TBL] [Abstract][Full Text] [Related]
19. Therapy for childhood acute lymphoblastic leukemia.
Cassano WF; Eskenazi AE; Frantz CN
Curr Opin Oncol; 1993 Jan; 5(1):42-52. PubMed ID: 8427893
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pediatric acute lymphoblastic leukemia.
Tucci F; Aricò M
Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
